ArticleJIMD reports2018

Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

William R Wilcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.